Longevity Biotech to Participate in Longevity Therapeutics Conference

Longevity Therapeutics Conference
January 28th, 2021

Longevity Biotech to Participate in Longevity Therapeutics Conference

Longevity Biotech CEO, Dr. Scott Shandler, Ph.D., will participate in the 3rd annual Longevity Therapeutics Conference held on January 27-28th, 2021.  Dr. Shandler will participate in a round table discussion on the 27th and share recent clinical insights from a recently completed Parkinson's disease biomarker study on the 28th.  Preliminary results including T-cell rebalancing (senescence and rejuvenation) as it relates to Parkinson's disease and inflammaging will be discussed. 

Click here of more information.